Product Details
Teva-Tobramycin
Tobramycin300 mg/5 mL
Solution for Inhalation
5-mL Pack
DIN/PIN/NPN
02389622
Manufacturer
Teva Canada Limited
Formulary Listing Date
2016-03-30
Unit Price
41.0985
Amount MOH Pays
41.0985
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Tobramycin 300 mg/5 mL Solution for Inhalation 5-mL Pack: For the management of cystic fibrosis patients with chronic pulmonary Pseudomonas aeruginosa (P. aeruginosa) infections. Tobramycin is administered in alternating periods of 28 days. After 28 days of therapy, patients should stop therapy for the next 28 days, and then resume therapy for the next 28 day on / 28 day off cycle.
ATC Code
J01GB01
Interchangeable Products
DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
---|---|---|---|
02239630 | TOBI | 60.8210 | 41.0985 |
02389622 | Teva-Tobramycin | 41.0985 | 41.0985 |